The Patent Finder

Crystalline Hydrochloride Salts of N-ETHYL-2-(5-Fluoro-1H-INDOL-3-YL)-N-METHYLETHAN-1-Amine

Gilgamesh Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 63/530,653, filed Aug 3, 2023. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,157,722Crystalline Hydrochloride Salts of N-ETHYL-2-(5-Fluoro-1H-INDOL-3-YL)-N-METHYLETHAN-1-Amine
In force
 · High confidence
UsedRemaining
Gilgamesh Pharmaceuticals, Inc.In forceHigh confidence
US 12,180,158Crystalline Fumarate Salts of N-ETHYL-2-(5-Fluoro-1H-INDOL-3-YL)-N-METHYLETHAN-1-Amine
In force
 · High confidence
Gilgamesh Pharmaceuticals, Inc.In forceHigh confidence
Application 18/930,314Crystalline Hydrochloride Salts of N-ETHYL-2-(5-Fluoro-1H-INDOL-3-YL)-N-METHYLETHAN-1-Amine
Pending
Not granted
Gilgamesh Pharmaceuticals, Inc.PendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Gilgamesh Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited